Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MD Biosciences Expands Preclinical Services | Contract Pharma

What are you searching for?

Sign in
Breaking News

MD Biosciences Expands Preclinical Services

Launches new suite of in vivo and in vitro cancer models

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

MD Biosciences has expanded its preclinical contract research services with a new suite of in vivo and in vitro cancer models. The company’s oncology research program specializes in murine solid tumors for subcutaneous and orthoptopic models (for example, advanced breast cancer and renal cancer) with a specific focus on the immune aspects of disease development and progression.
 
The services include both syngeneic and xenograft models with readouts for immune cell distribution, biomarkers, etc., end time-point primary/metastatic tumor evaluation, tumor tissue-specific cellular analysis using intravascular staining (cells: epithelial, endothelial, immune etc.), biomarker analysis and histological grading and evaluation of tumor specific tissue.
 
“Our onco-immunology research team is comprised of skilled scientists with deep-rooted expertise in a highly complex field,” said Eddie Moradian, MD Biosciences chief executive officer. “We at MD Biosciences are excited to bring our high level of expertise and our novel models to assist sponsors and partners in reaching their programs’ developmental goals. This new suite of capabilities compliments our existing, best-in-class services in other disease areas.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics